# Gestodene

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/gestodene
Canonical HTML page: https://getbiobrief.com/entity/gestodene

## Recent coverage (1 stories)

### 3M-Woman Study: 5 Contraceptive Hormones Elevate Meningioma Risk
2026-08-01 18:50:29 · Sentiment: Neutral · Impact: 5/10 · Sources: 3

The Danish Medicines Agency’s real-world evidence analysis implicates drospirenone, desogestrel, gestodene, and others in meningioma development, reshaping the risk-benefit landscape for pharmaceutical manufacturers and future contraceptive R&D.
Full story: https://getbiobrief.com/story/3m-women-contraceptive-hormones-meningioma-risk

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.